Formation of Hydroxyapatite-Based Hybrid Materials in the Presence of Platelet-Poor Plasma Additive

被引:2
作者
Glazov, Ilya E. E. [1 ]
Krutko, Valentina K. K. [1 ]
Safronova, Tatiana V. V. [2 ,3 ]
Sazhnev, Nikita A. A. [4 ]
Kildeeva, Natalia R. R. [4 ]
Vlasov, Roman A. A. [5 ]
Musskaya, Olga N. N. [1 ]
Kulak, Anatoly I. I. [1 ]
机构
[1] Natl Acad Sci Belarus, Inst Gen & Inorgan Chem, Surganova Str 9-1, Minsk 220012, BELARUS
[2] Lomonosov Moscow State Univ, Dept Chem, Bldg 3,Leninskie Gory 1, Moscow 119991, Russia
[3] Lomonosov Moscow State Univ, Dept Mat Sci, Bldg 73,Leninskie Gory 1, Moscow 119991, Russia
[4] Kosygin Russian State Univ, Dept Chem & Technol Polymer Mat & Nanocomposites, Malaya Kaluzhskaya 1, Moscow 119071, Russia
[5] Med Ctr Lode, Gikalo Str 1, Minsk 220005, BELARUS
关键词
hybrid material; hydroxyapatite formation; amorphous calcium phosphate; platelet-poor plasma; solubility; SBF; CALCIUM; FIBRIN; PRP;
D O I
10.3390/biomimetics8030297
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Biomaterials based on hydroxyapatite with controllable composition and properties are promising in the field of regenerative bone replacement. One approach to regulate the phase composition of the materials is the introduction of biopolymer-based additives into the synthesis process. The purpose of present study was to investigate the formation of hydroxyapatite-based hybrid materials in the presence of 6-24% platelet-poor plasma (PPP) additive, at a [Ca2+]/[PO43-] ratio of 1.67, pH 11, and varying maturing time from 4 to 9 days. The mineral component of the materials comprised 53% hydroxyapatite/47% amorphous calcium phosphate after 4 days of maturation and 100% hydroxyapatite after 9 days of maturation. Varying the PPP content between 6% and 24% brought about the formation of materials with rather defined contents of amorphous calcium phosphate and biopolymer component and the desired morphology, ranging from typical apatitic conglomerates to hybrid apatite-biopolymer fibers. The co-precipitated hybrid materials based on hydroxyapatite, amorphous calcium phosphate, and PPP additive exhibited increased solubility in SBF solution, which defines their applicability for repairing rhinoplastic defects.
引用
收藏
页数:12
相关论文
共 38 条
  • [1] Effect of platelet-poor plasma additive on the formation of biocompatible calcium phosphates
    Glazov, I. E.
    Krut'ko, V. K.
    Kulak, A. I.
    Musskaya, O. N.
    Vlasov, R. A.
    Malakhovsky, P. O.
    Kumar, V. G. Dileep
    Surya, P. S.
    Santosh, Mysore Sridhar
    Reddy, Narendra
    MATERIALS TODAY COMMUNICATIONS, 2021, 27
  • [2] Effects of platelet-rich plasma and platelet-poor plasma on human dermal fibroblasts
    Devereaux, Jeannie
    Nurgali, Kulmira
    Kiatos, Dimitrios
    Sakkal, Samy
    Apostolopoulos, Vasso
    MATURITAS, 2018, 117 : 34 - 44
  • [3] Proteomic analysis of platelet-rich and platelet-poor plasma
    Miroshnychenko, Olga
    Chalkley, Robert J.
    Leib, Ryan D.
    Everts, Peter A.
    Dragoo, Jason L.
    REGENERATIVE THERAPY, 2020, 15 : 226 - 235
  • [4] A comparative study between platelet-rich plasma and platelet-poor plasma effects on angiogenesis
    Minoo Shahidi
    Mousa Vatanmakanian
    Masoumeh Kourosh Arami
    Fatemeh Sadeghi Shirazi
    Najibeh Esmaeili
    Samaneh Hydarporian
    Soudeh Jafari
    Medical Molecular Morphology, 2018, 51 : 21 - 31
  • [5] A comparative study between platelet-rich plasma and platelet-poor plasma effects on angiogenesis
    Shahidi, Minoo
    Vatanmakanian, Mousa
    Arami, Masoumeh Kourosh
    Shirazi, Fatemeh Sadeghi
    Esmaeili, Najibeh
    Hydarporian, Samaneh
    Jafari, Soudeh
    MEDICAL MOLECULAR MORPHOLOGY, 2018, 51 (01) : 21 - 31
  • [6] Plasma Gel Made of Platelet-Poor Plasma: In Vitro Verification as a Carrier of Polyphosphate
    Nakamura, Masayuki
    Masuki, Hideo
    Kawabata, Hideo
    Watanabe, Taisuke
    Watanabe, Takao
    Tsujino, Tetsuhiro
    Isobe, Kazushige
    Kitamura, Yutaka
    Mourao, Carlos Fernando
    Kawase, Tomoyuki
    BIOMEDICINES, 2023, 11 (11)
  • [7] Low platelet-poor plasma levels of serotonin in adult autistic patients
    Spivak, B
    Golubchik, P
    Mozes, T
    Vered, Y
    Nechmad, A
    Weizman, A
    Strous, RD
    NEUROPSYCHOBIOLOGY, 2004, 50 (02) : 157 - 160
  • [8] Platelet-Poor and Platelet-Rich Plasma Stimulate Bone Lineage Differentiation in Periodontal Ligament Stem Cells
    Martinez, Constanza E.
    Gonzalez, Sergio A.
    Palma, Veronica
    Smith, Patricio C.
    JOURNAL OF PERIODONTOLOGY, 2016, 87 (02) : E18 - E26
  • [9] Platelet-rich and platelet-poor plasma: development of an animal model to evaluate hemostatic efficacy
    Pietrzak, William S.
    An, Yuehuei H.
    Kang, Qian K.
    Demos, Harry A.
    Ehrens, Karl H.
    JOURNAL OF CRANIOFACIAL SURGERY, 2007, 18 (03) : 559 - 567
  • [10] Protocol for Obtaining Platelet-Rich Plasma (PRP), Platelet-Poor Plasma (PPP), and Thrombin for Autologous use
    Pensato, Rosita
    Al-Amer, Rasmieh
    La Padula, Simone
    AESTHETIC PLASTIC SURGERY, 2023, 48 (13) : 2594 - 2595